Product description

Insulin lispro biphasic 25.Dosage form: susupension for subcutaneous injections in 3 ml cartridges and pre-filled disposable insulin pen.

·         Has fast and predictable effect and the elimination typical for physiologic insulin secretion.
·         Prandial component ensures faster and more predictable onset of action as well as fast elimination peculiar to physiologic insulin secretion, extended component ensures smooth peakless profile of basal insulin.
·         Onset of action after subcutaneous administration – in 15 minutes
·         0.5-2.5 hours – maximum action
·         Up to 15 hours – duration of action 


Read more

Specifications

Categories Biopharmaceuticals; BiopharmaceuticalsBiosimilars
Sales markets Middle East Region (e.g. UAE); Africa; Central America (e.g. Mexico); East Asia (e.g. China, Japan, Korea); Europe - EU countries; Europe - non EU (e.g. UK, Russia, ex-CIS countries); South America (e.g. Brazil, Colombia); South Asia (e.g. India, Pakistan, Sri Lanka); South East Asia (e.g. Thailand, Philippines, Singapore)
Supplied from Russian Federation

More products from Geropharm

CONTENT GROUP

CONTENT GROUP

Discover Aptar Pharma, the go-to drug delivery expert

Discover Aptar Pharma, the go-to drug delivery expert

Savior Lifetec. Co., the most qualified Carbapenem manufacture in world

Savior Lifetec. Co., the most qualified Carbapenem manufacture...

Glass Technology Services

Glass Technology Services

Discover Innovation with Softigel by Procaps

Discover Innovation with Softigel by Procaps